Vascular Calcification in CKD
View More View Less
  • 1 Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia
  • 1.

    Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697701, 1974 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, et al. : Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 18: 29182926, 2014 PubMed

    • Search Google Scholar
    • Export Citation
  • 3.

    London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 17311740, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. : Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 17371745, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, et al. : Multilineage potential of cells from the artery wall. Circulation 108: 25052510, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Chen NX, Kiattisunthorn K, O’Neill KD, Chen X, Moorthi RN, Gattone VH 2nd, et al. : Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 8: e64558, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    O’Neill WC: The fallacy of the calcium-phosphorus product. Kidney Int 72: 792796, 2007 PubMed

  • 8.

    Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. : Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 11191127, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, et al. : Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103: e28e34, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414422, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Viegas CSB, Santos L, Macedo AL, Matos AA, Silva AP, Neves PL, et al. : Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Arterioscler Thromb Vasc Biol 38: 575587, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Chen NX, O’Neill KD, Moe SM: Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways. Kidney Int 93: 343354, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al. : The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357366, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, et al. : The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 5: 568575, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Willems BA, Furmanik M, Caron MMJ, Chatrou MLL, Kusters DHM, Welting TJM, et al. : Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. Sci Rep 8: 4961, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Silva AP, Viegas CS, Mendes F, Macedo A, Guilherme P, Tavares N, et al. : Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study. J Clin Med 9: E635, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Jansen RS, Duijst S, Mahakena S, Sommer D, Szeri F, Váradi A, et al. : ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 34: 19851989, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, et al. : PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158: 543554, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, et al. : Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30: 824836, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Riser BL, Barreto FC, Rezg R, Valaitis PW, Cook CS, White JA, et al. : Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26: 33493357, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Lomashvili KA, Khawandi W, O’Neill WC: Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16: 24952500, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Tani T, Fujiwara M, Orimo H, Shimizu A, Narisawa S, Pinkerton AB, et al. : Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model. J Pathol 250: 3041, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Perelló J, Gómez M, Ferrer MD, Rodríguez NY, Salcedo C, Buades JM, et al. : SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels. J Nephrol 31: 287296, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, et al. : Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol 32: 811821, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Kang JH, Toita R, Asai D, Yamaoka T, Murata M: Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase. Heart Vessels 29: 718722, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Li X, Yang HY, Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199: 271277, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Hruska KA, Lanske B, Moe OW: Crosstalk between kidney and bone - Bench to bedside. Bone 100: 13, 2017 PubMed

  • 28.

    Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, et al. : CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25: 17601773, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, et al. : Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30: 499509, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Evenepoel P, D’Haese P, Brandenburg V: Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88: 235240, 2015 PubMed

  • 31.

    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, et al. : The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 93: 147158, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Gravesen E, Lerche Mace M, Nordholm A, Hofman-Bang J, Hruska K, Haagen Nielsen C, et al. : Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification. PLoS One 13: e0190820, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA: Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 89: 12311243, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, et al. : Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124136, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Shroff R, Shanahan CM: Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 22: 57, 2011 PubMed

  • 36.

    Viegas C, Araújo N, Marreiros C, Simes D: The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 11: 42744299, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 7: 159, 2017 PubMed

    • Search Google Scholar
    • Export Citation
  • 38.

    Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, et al. : Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 49: 417425, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Lewis JR, Wong G, Taverniti A, Vucak-Dzumhur M, Elder GJ: Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant Recipients. Am J Nephrol 50: 177186, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Pencak P, Czerwieńska B, Ficek R, Wyskida K, Kujawa-Szewieczek A, Olszanecka-Glinianowicz M, et al. : Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14: 10, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M, et al. : Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 30: 22892296, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132: 245250, 1997 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    Chau K, Martinez G, Elder GJ: Vascular calcification in patients undergoing kidney and simultaneous pancreas-kidney transplantation. Nephrology (Carlton) 19: 275281, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, et al. : A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19: 14801488, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol 4: 119127, 2009 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, et al. : Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 113: 118123, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, et al. : Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 17: 521527, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimäki T, Kilpinen S, et al. : Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis 18: 429438, 2009 PubMed

    • Search Google Scholar
    • Export Citation
  • 49.

    Farrar DJ, Bond MG, Riley WA, Sawyer JK: Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 83: 17541763, 1991 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50.

    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ; ESC Scientific Document Group: 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39: 30213104, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51.

    Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, et al. : Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. BMC Nephrol 18: 281, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52.

    Tholen S, Klofat K, Pan CR, Schmaderer C, Lutz J, Heemann U, et al. : Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens (Greenwich) 15: 833838, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53.

    Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG: Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 55: 11101115, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54.

    Lioufas N, Hawley CM, Cameron JD, Toussaint ND: Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. Int J Hypertens 2019: 9189362, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55.

    Kamath TP, Prasad R, Allison MA, Criqui MC, Ix JH, Rifkin DE, et al. : Association of Ankle-Brachial and Toe-Brachial Indexes With Mortality in Patients With CKD. Kidney Med 2: 6875, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56.

    Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, et al. : Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14: 15911598, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 57.

    Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A, et al. : Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis. Hypertens Res 37: 10501055, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 58.

    Gu X, Man C, Zhang H, Fan Y: High ankle-brachial index and risk of cardiovascular or all-cause mortality: A meta-analysis. Atherosclerosis 282: 2936, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59.

    Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, et al. : Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23: 17441752, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 60.

    Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, et al. : Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25: 339348, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61.

    Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, et al. ; CRIC Study Investigators: Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 73: 806814, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 62.

    Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, et al. : Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol 12: 315322, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 63.

    Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L: The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial. Clin J Am Soc Nephrol 13: 13731380, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64.

    Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, et al. : Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study. Nephrol Dial Transplant 33: 20432051, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65.

    Ter Meulen KJ, Dekker MJE, Pasch A, Broers NJH, van der Sande FM, van der Net JB, et al. : Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial. PLoS One 14: e0225824, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66.

    Spiegel DM, Brady K: Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int 81: 11161122, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 67.

    Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, et al. : Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 14071415, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 68.

    Toussaint ND, Pedagogos E, Lioufas NM, Elder GJ, Pascoe EM, Badve SV, et al. ; IMPROVE-CKD Trial Investigators: A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD). J Am Soc Nephrol 31: 26532666, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 69.

    Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, et al. : Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials. Am J Kidney Dis 68: 691702, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 70.

    Patel L, Bernard LM, Elder GJ: Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 11: 232244, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71.

    Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, et al. : A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. J Am Soc Nephrol 30: 14951504, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 72.

    Becs G, Zarjou A, Agarwal A, Kovács , Becs Á, Nyitrai M, et al. : Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells. J Cell Mol Med 20: 217230, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73.

    Ciceri P, Elli F, Braidotti P, Falleni M, Tosi D, Bulfamante G, et al. : Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis. Atherosclerosis 254: 93101, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74.

    de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, et al. : Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25: 37073717, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 75.

    Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF: Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8: 2069, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76.

    Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, et al. : Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56: 453462, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 77.

    Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A, et al. : Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 9: e89525, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 78.

    Herencia C, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Martinez-Moreno JM, Canalejo R, Montes de Oca A, et al. : Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx. Eur J Clin Invest 45: 11291144, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 79.

    Fragoso A, Silva AP, Gundlach K, Büchel J, Neves PL: Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients. Clin Kidney J 7: 161166, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 80.

    Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, et al. : Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35: 3139, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 81.

    Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, et al. : Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol 32: 791802, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 82.

    Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A: Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol 69: 309316, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 83.

    Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, et al. : A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. J Am Soc Nephrol 30: 10731085, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 84.

    Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L: The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale. BMJ Open 7: e016795, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 85.

    Neradova A, Schumacher SP, Hubeek I, Lux P, Schurgers LJ, Vervloet MG: Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study. BMC Nephrol 18: 149, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 86.

    Liabeuf S, Bourron O, Vemeer C, Theuwissen E, Magdeleyns E, et al. : Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein. Cardiovasc Diabetol 13: 85, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 87.

    Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, et al. : Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol 28: 17171722, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 88.

    Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, et al. : Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59: 186195, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 89.

    Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, et al. : Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant 29: 16331638, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 90.

    Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. : Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 134: 31003105, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 91.

    Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis 56: 5768, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 92.

    Ishida K, Ashizawa N, Matsumoto K, Kobashi S, Kurita N, Shigematsu T, et al. : Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats. J Bone Miner Metab 37: 796804, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 93.

    Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, et al. : Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 293: F946F955, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 94.

    Hénaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, et al. : Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res 101: 256265, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 95.

    Ureña-Torres PA, Floege J, Hawley CM, Pedagogos E, Goodman WG, Pétavy F, et al. : Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study. Nephrol Dial Transplant 28: 146152, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 96.

    Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I, et al. : The Key Role of Phosphate on Vascular Calcification. Toxins (Basel) 11: E213, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 97.

    Holt SG, Smith ER: Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. Nephrol Dial Transplant 31: 15831587, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 98.

    de Oliveira RB, Stinghen AEM, Massy ZA: Vitamin K role in mineral and bone disorder of chronic kidney disease. Clin Chim Acta 502: 6672, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 564 564 155
Full Text Views 228 228 42
PDF Downloads 181 181 63